- Home
- ADI vs CI Comparison
ADI vs CI Comparison
Compare ADI & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADI
- CI
- Stock Information
- Founded
- ADI 1965
- CI 1792
- Country
- ADI United States
- CI United States
- Employees
- ADI N/A
- CI N/A
- Industry
- ADI Semiconductors
- CI Medical Specialities
- Sector
- ADI Technology
- CI Health Care
- Exchange
- ADI Nasdaq
- CI Nasdaq
- Market Cap
- ADI 88.5B
- CI 81.7B
- IPO Year
- ADI 1972
- CI N/A
- Fundamental
- Price
- ADI $176.27
- CI $330.13
- Analyst Decision
- ADI Buy
- CI Strong Buy
- Analyst Count
- ADI 22
- CI 17
- Target Price
- ADI $252.14
- CI $379.35
- AVG Volume (30 Days)
- ADI 5.2M
- CI 2.0M
- Earning Date
- ADI 05-21-2025
- CI 05-02-2025
- Dividend Yield
- ADI 2.25%
- CI 1.83%
- EPS Growth
- ADI N/A
- CI N/A
- EPS
- ADI 3.13
- CI 12.12
- Revenue
- ADI $9,337,627,000.00
- CI $247,121,000,000.00
- Revenue This Year
- ADI $10.58
- CI $5.05
- Revenue Next Year
- ADI $12.84
- CI $4.66
- P/E Ratio
- ADI $56.32
- CI $27.24
- Revenue Growth
- ADI N/A
- CI 26.56
- 52 Week Low
- ADI $158.65
- CI $262.03
- 52 Week High
- ADI $247.10
- CI $370.83
- Technical
- Relative Strength Index (RSI)
- ADI 39.65
- CI 58.11
- Support Level
- ADI $170.39
- CI $309.06
- Resistance Level
- ADI $185.00
- CI $335.16
- Average True Range (ATR)
- ADI 12.65
- CI 10.32
- MACD
- ADI -0.26
- CI -0.17
- Stochastic Oscillator
- ADI 40.16
- CI 61.81
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
About CI The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.